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ABSTRACT: Organic small-molecule photosensitizers are well-characterized and known for the light-responsive treatment modality
including photodynamic therapy. Compared with ultraviolet−visible
(UV−vis) light used in conventional photodynamic therapy with
organic photosensitizers, near-infrared (NIR) light from 700 to 900 nm
is less absorbed and scattered by biological tissue such as hemoglobin,
lipids, and water, and thus, the use of NIR excitation can greatly
increase the penetration depth and emission. Additionally, NIR light has
lower energy than UV−vis that can be beneﬁcial due to less activation
of ﬂuorophores present in tissues upon NIR irradiation. However, the
low water stability, nonspeciﬁc distribution, and short circulation halflife of the organic photosensitizers limit its broad biological application.
NIR responsive small-molecule ﬂuorescent agents are the focus of
extensive research for combined molecular imaging and hyperthermia. Recently a new class of NIR dye, IR-820 with excitation and
emission wavelengths of 710 and 820 nm, has been developed and explored as an alternative platform to overcome some of the
limitations of the most commonly used gold nanoparticles for photothermal therapy of cancer. Herein, we synthesized a core−shell
biocompatible nanocarrier envelope made up of a phospholipid conjugated with poly(ethylene glycol) as a shell, while poly(lactic
glycolic acid) (PLGA) was used as a core to encapsulate IR-820 dye. The IR-820-loaded nanoparticles were prepared by
nanoprecipitation and characterized for their physicochemical properties and photothermal eﬃciency. These nanoparticles were
monodispersed and highly stable in physiological pH with the hydrodynamic size of 103 ± 8 nm and polydispersity index of 0.163 ±
0.031. The IR-820-loaded nanocarrier showed excellent biocompatibility in the dark, whereas remarkable phototoxicity was observed
with breast cancer cells (MCF-7) upon NIR laser excitation. Therefore, the IR-820-loaded phospholipid mimicking biodegradable
lipid-polymer composite nanoparticles could have great potential for cancer theranostics.

■

INTRODUCTION
With the progress of nanotechnology, there has been
considerable attention in the treatment of cancer using thermal
therapies such as magnetic hyperthermia, microwave-assisted
hyperthermia, photosensitizer-induced photodynamic therapy,
and plasmonic nanoparticle-mediated photothermal therapy
(PTT) due to their high tumor ablation eﬃciency, good spatial
resolution, and minimal side eﬀects.1−6 The most common
feature in the aforementioned modalities is the use of heat
energy to modulate cancer cells. Near-infrared (NIR) responsive
ﬂuorescent agents are the focus of extensive research for
combined molecular imaging and hyperthermia. A key
advantage of the PTT strategy is the fact that photothermal
agents are capable of annihilating cancer cells with remote light
irradiation while causing minimal damage to normal tissues.6 On
the one hand, in contrast to inorganic nanoparticles such as
super-paramagnetic iron oxide nanoparticles and gold nanoparticles, NIR-absorbing small-molecule organic dyes overcome
the issue of metal-induced toxicity such as redox-active and
unknown metabolic pathways when incorporated in a suitable
© 2022 The Authors. Published by
American Chemical Society

envelope and thus are generally considered to be more
biocompatible.7−12 On the other hand, optical imaging is
inexpensive with good resolution, easy to handle, and can be
made portable oﬀering broad application when compared to
other modalities such as magnetic resonance imaging, computed
tomography, or positron-emitting tomography,13−15 thanks to
the advancement in ﬁber optics technology that makes optical
imaging ideal for incorporation into an endoscope used in
minimally invasive procedures. However, conventional optical
imaging that uses the light of lower wavelengths in the
ultraviolet−visible (UV−vis) region suﬀers due to high light
scattering and absorption by tissues.16 Instead, NIR light of
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salt (DSPG), and phospholipid conjugated l-α-phosphatidylethanolamine-N-(lissamine rhodamine-B sulfonyl) (ammonium
salt) (RhB) was purchased from Avanti Polar Lipid Inc.
(Alabaster) and used as received. 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI), (3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide) (MTT), acetonitrile, and
dimethyl sulfoxide (DMSO) were purchased from SigmaAldrich. IR-820 (CAS No. 172616-80-7) dye was purchased
from BOC Sciences, and Annexin V/propidium iodide (PI)
stain was purchased from BD Bioscience. All other analytical
grade reagents and solvents were used without further
puriﬁcation.
Human breast cancer (MCF-7) and Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM) were purchased from American Type
Cell Culture (ATCC). Fetal bovine serum (FBS) USDA
Premium Select, heat-inactivated, was purchased from MIDSCI.
Cells were maintained in DMEM supplemented with 10% (v/v),
FBS and 1% streptomycin at 37 °C in a 5% CO2 environment.
When cells reached 80−90% conﬂuency in T75 cell culture
ﬂasks, they were passaged or plated by detaching the cells from
the ﬂask using Trypsin−ethylenediaminetetraacetic acid
(EDTA) (Thermo Fisher) and then counting the cells with a
hemocytometer. The cell lines were used from passage 10 for
bionano interaction studies.
Preparation of IR-820 Encapsulated Nanoparticles.
PLGA with a carboxylic acid-terminated end group of molecular
weight 50 kDa was used to synthesize IR-820 encapsulated
PLGA nanoparticles following the well-established nanoprecipitation protocol.31−38 In a typical experiment, the
calculated amount of IR-820 in DMSO was physically adsorbed
with 1 mg of PLGA in acetonitrile and made the ﬁnal volume of
the mixture to 1 mL to prepare IR-820-encapsulated PLGA
nanoparticles. Then the phospholipids that consist of lipid
mixture formulations having 260 μg of DSPE-PEG and 200 μg of
DSPG were used in 4% ethanol, respectively. This lipid mixture
was stirred at 60 °C for 30 min, and then an IR-820 encapsulated
PLGA nanoparticle solution was added dropwise to the lipid
suspension with stirring followed by the addition of 1 mL of
deionized water (acetonitrile/water = 1:3). The content was
further stirred at room temperature for 1 h to facilitate the
formation of nanoparticles. The IR-820 encapsulated PLGA
nanoparticles thus formed were puriﬁed using a 10 kDa Amicon
wash at 3500 rpm for 10 min. The washing was done three times
in 1X phosphate-buﬀered saline (PBS), made to a ﬁnal
concentration of 1 mg/mL in 1X PBS, and stored at 4 °C
until further use. Similarly, control nanoparticles were prepared
in the same phospholipid ratio and PLGA content without IR820.
Characterization of Nanoparticles. The morphology of
the puriﬁed NPs was characterized using a transmission electron
microscope (TEM) (FEI Technai G2 Spirit BioTWIN). TEM
samples were prepared by incubating 20 μL of IR-820 PLGA
NPs (1 mg/mL) with 20 μL of 0.1% uranyl acetate for 5 min at
room temperature. The sample was then placed on a Formvarcoated copper grid (400 mesh) and let stand for an additional 20
min. The excess amount of sample was removed before image
acquisition. TEM images were acquired at 120 kV and analyzed
by the GATAN digital imaging system (GATAN, Inc.).
Similarly, NPs were characterized for hydrodynamic size and
zeta potential measurements using a Malvarian Zeta sizer Nano.
In this instrument, the Brownian motion and the Smoluchowski
equation were used to calculate the average hydrodynamic size
and zeta potential value, respectively. The colloidal stability of

wavelengths from 700 to 900 nm has a deep tissue penetration
limit owing to minimal scattering and tissue absorption.17 Small
organic molecule ﬂuorescent probes that absorb energy in the
NIR region will release vibrational energy in the form of heat
following exposure to light illumination and can kill cancer cells
similar to that of plasmonic PTT mediated by noble-metal
nanoparticles.13
Indocyanine green is a tricarbocyanine-type dye with NIRabsorbing properties approved for visualization of retinal and
choroidal vasculature, blood volume determination, and photodynamic therapy.11,12,18,19 However, the low water stability and
short circulation half-life limit its broad application for
hyperthermia and in vivo imaging.20 To address these issues,
the use of IR-820 dye as a potential alternative has been
described in the literature.7,21−25 IR-820 dye has similar
structural and optical characteristics to those of indocyanine
green with a relatively longer absorption range through maximal
excitation and emission wavelengths of 710 and 820 nm,
respectively. Prajapati and colleagues reported the use of IR-820
as a blood pool contrast agent to image tissue injuries and
tumors in mice with improved circulation half-life compared to
the indocyanine green.25 In an in vivo study by Pandey and
colleagues, they conjugated IR-820 with a photodynamic
therapy drug and studied its potential for dual imaging and
thermotherapy.26 Although these reports indicate that IR-820
has the potential for in vivo applications and provides an
attractive alternative to metallic nanoparticles, there is still more
for the ﬁeld to provide a detailed in vitro characterization
regarding its photothermal eﬃciency and cellular behavior in
nanoformulations.
When an NIR dye, as an organic photothermal agent, is
encapsulated into a suitable delivery vehicle, it can be selectively
activated by the external stimulus such as light after the dye has
reached its intended target, for example, tumor oﬀering an
image-guided treatment platform. The incorporation of the
photothermal agent into self-assembled polymeric nanocarriers
confers several beneﬁts to PTT including biodegradability,
scalability, and reproducibility.26−29 Herein, we designed a lipid
polymer-based core−shell nanocarrier by encapsulating the
indocyanine class of IR-820 dye into the polymeric form for the
photothermal treatment of breast cancer. These lipid−polymer
hybrid nanocarriers delivered IR-820 to MCF-7 breast cancer
cells as a potent mediator of PTT exhibiting signiﬁcant cytotoxic
eﬀects upon excitation with a clinically approved external laser
light stimulus. The results also showed that these NPs induced
cell death primarily through apoptosis, a preferred cell-death
pathway over necrosis that may lead to the recurrence and
metastasis of tumors.30 With the great success of photothermal
cancer treatment in vitro, this approach exhibits promising
potential for in vivo applications. Furthermore, the photothermal treatment modality could be improved by combining
NIR-responsive agents with anticancer drugs or photosensitizers
for combination therapy like photothermal−chemotherapy or
photothermal−photodynamic therapy to maximize their therapeutic eﬃcacy with a synergistic cancer treatment.

■

MATERIALS AND METHODS
Chemicals and Reagents. Carboxylic end group terminated PLGA (lactide/glycolide = 50:50 dL g−1) was purchased
from the DURECT Corporation and used after puriﬁcation by
repeated precipitation in diethyl ether. 1,2-Distearoylphosphatidylethanolamine poly(ethylene glycol succinyl) (DSPE-PEGCOOH), 1,2-distearoyl-sn-glycero-3-phosphoglycerol, sodium
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NPs was investigated in both ionic and serum conditions to
mimic the biological environment. In brief, 1 mg of NPs
dispersed in the medium was subjected to a hydrodynamic size
analysis over the period to obtain size, polydispersity index
(PDI), and zeta potential values. The reported intensity-based
hydrodynamic diameter is the z-average of three measurements,
while the total count-based zeta potential is also the average of
three measurements. The formulation with low PDI, high
stability, and uniform narrow size distribution was selected for
the in vitro application. Likewise, the stability of IR-820 dye in
NPs was studied by mixing 500 μL of IR-820 encapsulated NP
and 500 μL of 1X PBS (n = 3) over the period to ensure the
dispersity and colloidal stability of NPs in physiological media.
The size and PDI of the particles after being dispersed in PBS
was measured each day for a week using dynamic light scattering
(DLS).
The optical properties of IR-820 PLGA NPs were
characterized by ultraviolet−visible spectrophotometry (BIOMATE-3S, Thermo Scientiﬁc) with 1.0 mm path length quartz
cuvettes based on reading the absorbance of the NPs at 710 nm
and comparing to a standard curve of known dye concentration
dissolved in DMSO with dilution as required. The samples were
scanned from 400 to 1100 nm with a baseline correction. The
amount of IR-820 released from the NPs while in storage
conditions was also examined by UV−vis spectroscopy. At
several time points between 0 and 7 d post preparation, samples
were centrifuged using a 10 kDa Amicon ﬁlter to separate the
NPs from released IR-820, and the collected released IR-820 was
compared to a standard curve of known dye concentration using
the same scanning conditions as described above. The dye
release study was performed three times, and the average and
standard deviation of all three trials are reported.
For the IR-820 dye loading and release study, IR-820 was
loaded on PLGA NPs by the direct mixing of a known
concentration of dye into the PLGA polymer followed by the
nanoprecipitation technique.39−42 To optimize the maximum
IR-820 loading, diﬀerent calculated amounts such as 150, 300,
and 400 μg of IR-820 were initially fed with 1 mg of PLGA
dissolved in 400 μL of acetonitrile solution. The amount of
encapsulated IR-820 was quantiﬁed, after puriﬁcation, spectrophotometrically using a UV−vis spectrophotometer by
measuring the absorbance of the NPs at 710 nm. The drug
loading eﬃciency was calculated using the following equation.

Article

%cumulative IR‐820 release = (IR‐820 in release
media/IR‐820 in 100%release) × 100

The photothermal eﬃciency of free IR-820 and IR-820 PLGA
NPs was measured in an aqueous suspension upon 808 nm laser
(China Deheng Group, Inc.) irradiation with a thermal camera
imaging system (Forward Looking InfraRed FLIR A5 systems).
Samples were suspended in PBS at an IR-820 concentration of
20−120 μM with a total volume of 1 mL in the Eppendorf tube.
The free dye and IR-820 PLGA NPs were then irradiated with a
continuous-wave constant diode laser power of 808 nm laser for
2 min at varying power densities from 5.3 to 21.2 W/cm2 while
maintaining an ∼1 cm distance between the laser and sample.
The concentration dependence of the photothermal eﬃciency
for IR-820 PLGA NPs was examined by irradiating nanoparticles
at concentrations of 20, 60, or 120 μM of IR-820 content with
the 808 nm laser set to diﬀerent power densities for 2 min. The
temperature in each sample was recorded once every 30 s during
irradiation, and the experiments were repeated three times. To
further evaluate the inﬂuence of NIR laser exposure on the
optical and physical properties of the NPs, we recorded the
absorbance spectra, hydrodynamic diameter, and polydispersity
index of IR-820 PLGA NPs by UV−vis spectroscopy and DLS
both before and after irradiation.
Cellular Biocompatibility and NIR-Mediated Phototoxicity Study. The in vitro biocompatibility of free IR-820 dye
and IR-820 PLGA NPs was conducted in MCF-7 cells using a
colorimetric assay for assessing cell metabolic activity by an
MTT assay. A time-dependent MTT assay in dark was
conducted as discussed in the literature.43−46 In brief, cells at
a density of 1 × 104 cells per well in a 96-well plate were
incubated overnight. The seeded cells were washed twice with
1X PBS to remove the debris before NPs treatment. Then the
medium was replaced with various concentrations of NPs (0.01,
0.1, 0.5, 5, 10, 25, 50,100, 200 μg/mL) suspended in DMEM.
The control cell was maintained without treatment. After 24 h of
incubation, cells were washed with 1X PBS to remove surfaceabsorbed and excess NPs. After the washing, 100 μL of MTT (5
mg/mL in PBS, ﬁltered through a 0.22 μm syringe) reagent was
added to each well following the manufacturer’s recommendation. Then the supernatant was aspirated followed by the
addition of 100 μL of DMSO for solubilizing formazan crystal.
The plate was gently shaken in an orbital shaker for 5 min in the
dark, and absorbance was recorded at 560 nm using a microplate
reader (BioTek, Synergy H1 hybrid reader). To analyze the data,
the background (DMSO only) was subtracted from the
absorbance reading in each well. Triplicate well signals were
averaged and then normalized to untreated cells. These
experiments were performed in triplicate and analyzed by
Student’s t-tests at each concentration.
The in vitro phototoxicity of IR-820 or IR-820 PLGA NPs was
conducted in cells seeded as described above and treated with
IR-820 PLGA NPs at the IR-820 concentration of 60 μM or with
fresh media for 24 h of incubation at 37 °C. The cells were then
washed with PBS and incubated in fresh media for 1 h to bring
the temperature to 37 °C. The appropriate wells were then
irradiated with continuous-wave 808 nm light at 14.1 W/cm2 for
30 s/well such that the treatment groups included no treatment,
laser light only, IR-820 PLGA NPs only, or IR-820 PLGA NPs
with laser light with an ∼1 cm distance between the laser and
sample. The irradiation was performed at room temperature,
and the sample was returned to the 37 °C incubator immediately

%loading efficiency = (amount of encapsulated
IR‐820/amount of initial IR‐820input) × 100

The cumulative free IR-820 dye release from IR-820 PLGA
NPs and free IR-820 (Mw = 849.47) was studied using 3.5 kDa
molecular cutoﬀ dialysis bags at physiological pH (pH 7.4, PBS).
For this purpose, 300 μg of IR-820 input formulation was
selected for further studies due to the stable physiochemical
properties. Free IR-820 release from selected formulations was
tracked throughout 72 h by dialysis. One milliliter of IR-820
PLGA containing 1 mg/mL of NPs or an equivalent
concentration of free IR-820 dye was dialyzed in 200 mL of
PBS release media kept at 37 °C, while constant stirring (80
rpm) was maintained to retain the sink condition during the
experiment. One milliliter of release media was taken at a regular
interval and replaced with equivalent fresh media. The amount
of free IR-820 in the release media was quantiﬁed spectrophotometrically, and the cumulative release percentage was calculated
using the following equation.
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Figure 1. Morphology, size, and photostability of IR-820-PLGA NPs. (A) TEM image of IR-820-PLGA NPs. (B) Hydrodynamic size with diﬀerent
initial input of IR-820 concentration (150−400 μg) per milligram of PLGA NPs. (C) Zeta potential of IR-820 and IR-820 PLGA NPs. (D, E) Optical
properties (absorption proﬁles) of free IR-820 dye and IR-820 PLGA NPs in water before and after storage at 4 °C, as determined by UV−vis
spectrophotometry. The concentration of IR-820 is 60 μM (corresponding to 300 μg input) for both free and encapsulated dye. (F) Stability of
particles over storage. Data represent n = 3.

Cells were then treated with 0, 20, or 60 μM IR-820 content in
IR-820 PLGA NPs prepared as described above and incubated
for 3 h to evaluate dose dependency. After 3 h, the cells were
rinsed with 1X PBS, lifted oﬀ the plate with Trypsin−EDTA, and
resuspended in 500 μL of 1X PBS to yield a single cell
suspension of 1 × 106 cells that were analyzed by BD LSR
Fortessa X-20 Special Order Research Product Flow Cytometer.
Control cells were maintained without any treatments. 10 000
gated events were collected for all measurements. Density plots
showing forward and side scatter data were used to create a
primary gate for cells, excluding debris, prior to analyzing IR-820
PLGA NPs content.
Investigation of the Mechanism of Cell Death Induced
by PTT. To analyze the mechanism of cell death induced via
PTT mediated by IR-820 PLGA NPs, cells were seeded at 3 ×
105 cells per well in a 24-well plate and incubated overnight.
Cells were then treated with 20 μM of IR-820 content in IR-820
PLGA NPs for 3 h, at which time the cells were rinsed with 1X
PBS and the wells were replenished with fresh media. The
appropriate wells were then irradiated with continuous-wave
808 nm light at 14.1 W/cm2 for 30 s per well for the following
groups of samples: no treatment, cells with laser light only, IR820 PLGA NPs only, or IR-820 PLGA NPs with laser light. After
the laser light treatment, the samples were returned to the
incubator. After 24 h, an Annexin V/PI staining was conducted
as per the manufacturer’s recommendations. Brieﬂy, cells were
lifted from the plate with Trypsin−EDTA, washed with 1X
binding buﬀer, and resuspended in 100 μL of binding buﬀer
containing 1:500 Annexin V and 1:1000 PI stains for 15 min in
the dark condition. The samples were then diluted with 300 μL
of 1X binding buﬀer and analyzed on the BD LSR Fortessa X-20
Special Order Research Product Flow Cytometer with FITC
(excitation, 488 nm; emission, 530/30 nm) and PerCP
(excitation, 488 nm; emission, 675/30 nm) channels. Density
plots showing forward and side scatter data were used to create a
primary gate for cells, excluding debris, before establishing gates

following irradiation. After 24 h, the MTT assay was performed
as described above. Data obtained were compared side-by-side
with the control experiment to map the relative toxicity. Data
shown are from three experiments that were each run with
triplicate wells, and the data were analyzed by a one-way analysis
of variance (ANOVA) with post hoc Tukey.
Intracellular Uptake Study. To evaluate the cellular
internalization competence of IR-820 PLGA NPs, experiments
were conducted with MCF-7 cells using confocal microscopy
and ﬂow cytometry studies.47 For the confocal study, cells were
seeded on poly-D-lysine-coated eight-chamber slides at a density
of 50 000 cells per well and incubated for 24 h. Then the cells
were treated with 50 μg/mL rhodamine-lipid labeled IR-820
PLGA NPs suspension prepared in complete DMEM and
incubated for 3 h. After the incubation, the treated cells were
washed twice with 1X PBS (pH = 7.4) and ﬁxed with 4%
paraformaldehyde for 30 min at room temperature. The nucleus
of the cells was stained with DAPI for an additional 10 min and
imaged under a confocal laser scanning microscope (Carl Zeiss,
CLSM-700). Cells without any treatment served as control cells.
The quantitative percentage of ﬂuorescence intensity was
determined using the Image-J software. The quantiﬁcation of
the intensity of internalized RhB-lipid labeled NPs was
calculated in terms of corrected total cell ﬂuorescence
(CTCF) by use of the following equation.
CTCF = integrated density − (area of selected
cell × mean fluorescence of background readings)

To investigate the quantitative cellular uptake of IR-820
PLGA NPs, a ﬂuorescence-activated cell sorting (FACS) study
was conducted after we labeled NPs with rhodamine B-lipid dye
using lipid insertion followed by the nanoprecipitation
technique described above.31,32,46 In brief, MCF-7 cells with
passage 10 were plated at the density of 1 × 105 cells per well on
poly-D-lysine-coated 24-well plates and incubated overnight.
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Figure 2. IR-820 loading and release study. (A) IR-820 loading into PLGA NPs. (B) Hydrodynamic size with diﬀerent initial input of IR-820
concentration (150−400 μg) per milligram of PLGA NPs. (C) Cumulative dye-release kinetics from free IR-820 and IR-820 PLGA NPs at
physiological condition (PBS at pH 7.4). The concentration of IR-820 is 60 μM (corresponding to 300 μg input) for both free IR-820 and IR-820
PLGA NPs. Data represent n = 3.

to 0.163, and the size varied from 97 to 108 nm. Taken together
with optical properties, these characterization data show
minimum variation during the storage condition signifying
better stability and the retention of dye in the NPs compared to
the free dye solution.
Next, we studied the dye loading and release kinetics to
explore the potential application of IR-820 in the drug delivery
platform for PTT. IR-820 dye was used as a photoresponsive
agent. The IR-820 dye was loaded into PLGA NPs using the
lipid insertion mediated nanoprecipitation technique. As shown
in Figure 2A, the percentage loading eﬃciency of dye with
respect to the various initial input concentrations of dye was
calculated. Our synthetic protocol yielded a high loading
eﬃciency of 84%−96% with input IR-820 concentration ranging
from 400 μg to 150 μg/mg polymer, respectively. Unfortunately,
in the case of high loading content with 400 μg, IR-820 is
aggregated, as observed from the increased size and bimodal
distribution (Figure 2B). However, in the case of 300 μg IR-820
initial input, the size and PDI of NPs after loading (103 nm,
0.135 PDI) was similar to that before loading (96 nm, 0.112
PDI), as shown in Figure 1B. Also, the loading eﬃciency was
93%, and the percentage of dye content (%wt) to the carrier was
1.37%. So, among the diﬀerent formulations studied, it was
found that 300 μg/mg polymer showed the best stability in
media while maintaining its loading content. Therefore, we
chose the 300 μg/mg polymer input formulation as a standard
for further experiments. No signiﬁcant changes in the size and
PDI of this formulation were observed when incubated at 37 °C
for 7 d in PBS (pH = 7.4), conﬁrming the excellent
physicochemical properties (Figure 1F). To determine the
release eﬃciency of the dye from the NPs, 2 mL samples of 1
mg/mL were placed in a dialysis bag and processed under
identical conditions. We observed burst and sustained dyerelease kinetics for free IR-820 and IR-820 PLGA NPs over a 72
h period at 37 °C (pH = 7.4), respectively. On the one hand, the
results, as shown in Figure 2C, indicate that ∼36% IR-820 was
released within a period of 1 h, while, over 12 h, we observed
∼90% in dye-release kinetics. On the other hand, we found a
higher order of dye stability in the IR-820 PLGA NPs. Less than
20% of IR-820 was released throughout the release study period
of 72 h. These data are consistent with the literature with the
release of similar lipophilic dyes such as DiR dye or indocyanine
green from the nanoparticles.22,25,39,40,48 The stability of the dye
is highly essential in device NPs for a theragnostic application.
IR-820-Mediated Photothermal Eﬃciency. The concentration dependence and laser power dependence photothermal
eﬃciencies of free IR-820 and IR-820 PLGA NPs were

for Annexin V-positive and PI-positive cells. 10 000 gated events
were collected for all measurements. Positively stained gates
were based on unstained cells, and single-stained controls
including Annexin V only, PI only, or free IR-820 dye were used
for compensation. The data presented are the average of three
experiments and were analyzed by one-way ANOVA.
Data and Statistical Analysis. The obtained data were
plotted and compared to the signiﬁcance of the results using
GraphPad software. Diﬀerent statistical models and tests were
performed including a t-test, F-test, and dose−response
inhibition model ﬁt using GraphPad software according to the
requirement. All data represent the mean ± standard deviation.
Biocompatibility and cytotoxicity data include six replicates (n =
6). All other major data include at least three replicates (n = 3).

■

RESULTS AND DISCUSSIONS
Physiochemical Characterization. The nanoparticles
were fabricated using the nanoprecipitation technique. The
morphology of IR-820 PLGA NPs was characterized by TEM
and DLS, which showed that the nanoparticles were spherical,
uniformly distributed, and had the hydrodynamic diameter of
103 ± 8 nm (Figure 1A,B). The encapsulation of IR-820 dye has
no signiﬁcant impact in the diameter of nanoparticles as
compared to the control particles without dye, which has a size
of 96 ± 3 nm. These nanoparticles were negatively charged with
a zeta potential value of −28 ± 7 mV (Figure 1 C), as compared
to the slightly negative charge (−1.6 ± 2 mV) of free IR-820 in
aqueous condition. No signiﬁcant change in the surface zeta
potential further assured us that the IR-820 dye is loaded into
the core of the NP. The negative charge in IR-820 PLGA NPs is
due to the presence of the carboxylic acid-terminated
phospholipid PEG moiety. The optical property of the particles
including free IR-820 and IR-820 PLGA NPs by using UV−vis
spectroscopy revealed a characteristic extinction spectrum peak
at 710 nm of free dye that is shifted further to the longer
wavelength by 15 nm, red-shift, after loading into the
nanoparticles (Figure 1D,E). To evaluate the stability and
retention of optical properties of IR-820 dye free in solution or
loaded into the NPs, we analyzed the extinction spectrum of
freshly prepared samples and samples that had been stored at 4
°C for three weeks. After storage in MilliQ water, we observed
that free IR-820 dye loses its absorption capabilities, whereas IR820 PLGA NPs fairly maintain their optical properties (Figure
1D,E). To further examine the stability of IR-820-loaded PLGA
NPs, we evaluated the colloidal stability by monitoring the
hydrodynamic size and PDI up to 7 d as shown in Figure 1F.
During 7 d of incubation time, the PDI of NPs varied from 0.116
12060
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Figure 3. Comparative photothermal eﬃciency of free IR-820 dye and IR-820 PLGA NPs. (A) The concentration and power-dependent NIR laser (λ
= 808 nm) heating thermograph proﬁle of IR-820 PLGA NPs and free IR-820 dye suspension upon laser irradiation. Three diﬀerent laser power
densities 5.3, 14.1, and 21.2 W/cm2 and 20, 60, and 120 μM IR-820 dye corresponding to 150, 300, and 400 μg input/mg polymer were irradiated for 2
min with the laser-to-sample distance of ∼1 cm. The evolution of temperature throughout the suspension was recorded using an FLIR thermal camera
system. (B) The corresponding temperature plots showing the average change in temperature as a function of time from (A). Data represent n = 3.

Figure 4. Optical response and alteration in the size of IR-820 PLGA NPs after laser exposure. (A, B) UV−Vis absorption proﬁle showing the changes
in optical density of free IR-820 dye and IR-820 PLGA NPs before and after laser irradiation. (C) Changes in the hydrodynamic size of PLGA NPs and
IR-820 PLGA NPs after laser exposure measured by DLS. These data were recorded for the laser power density of 14.1 W/cm2 and 60 μM IR-820 dye
content either in free dye or in NPs that were irradiated for 2 min.

content ranging from 20 to 120 μM. The temperature was
increased from 6.5 to 33.3 °C and from 8 to 33.6 °C while from
9.4 to 34.2 °C and from 10.2 to 35 °C for free IR-820 and IR-820
PLGA NPs at 14.1 and 21.2 W/cm2, respectively. Interestingly,
we did not ﬁnd a signiﬁcant diﬀerence in heat evolution at 14.1
versus 22.2 W/cm2 irrespective of the sample. To investigate the
eﬀect of laser exposure to the optical and physicochemical
properties of IR-820 PLGANPs or free IR-820, we recorded the
UV−vis spectra and size of the particles. We observed a
signiﬁcant reduction in the absorption peak of free IR-820 but a
lesser eﬀect of laser in the case of IR-820 PLGA NPs after a laser
exposure of 2 min (Figure 4A,B). As shown in Figure 4C, we did
not have much eﬀect on laser irradiation in terms of size and PDI
of the IR-820 PLGA NPs. However, during the NIR exposure, a
change in the color of the free IR-820 suspension was observed,
which was conﬁrmed by recording the change in optical density
and absorption peak, as can be seen in Figure 4A. This is

investigated under 808 nm NIR laser irradiation using three
diﬀerent concentrations of IR-820 from 20 to 120 μM and
power densities of 5.3, 14.1, and 21.2 W/cm2. All samples
suspended in an aqueous solution were irradiated where the
change in temperature versus time was noted using a thermal
imaging system at an interval of 30 s. As shown in Figure 3, a
time-dependent increase in temperature was observed in all
samples. As expected, we observed low heat evolution at a lower
concentration of dye or laser power used for both samples.
However, we did not observe any bigger diﬀerence in the
temperature rise between free IR-820 dye or IR-820 PLGA NPs
at an identical dye content. As a general trend, we found that IR820 PLGA NPs produced more temperature compared to the
free IR-820 under identical conditions of dye concentration and
laser power used (Figure 3A,B). At 5.3 W/cm2, free IR-820
increased the temperature (ΔT) from 3.7 to 19 °C, while IR-820
PLGA NPs increased from 6 to 20.4 °C under similar dye
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Figure 5. Cellular interaction study in MCF-7 cells. (A) Concentration-dependent relative cell viability of MCF-7cells exposed to PLGA NPs or IR820 PLGA NPs without light exposure. (B) Concentration-dependent cell relative viability of MCF-7 cells exposed to free IR-820 dye. The
concentration of IR-820 was used similar to the IR-820 content encapsulated in PLGA NPs as shown in (A). (C) Confocal microscopic micrographs
capture Rh−B-lipid labeled IR-820 PLGA NPs cellular internalization at 3 h of incubation, and (D) corresponding FACS analysis (Data represent n = 6
for biocompatibility and n = 3 for FACS study).

Figure 6. NIR-mediated phototoxicity study and its mechanism of cell death in MCF-7 cells. (A) A comparative power-dependent PTT using either
cells, PLGA NPs, free IR-820, or IR-820 PLGA NPs (60 μM) with laser exposure for 30 s. These data were recorded for the laser power density of 5.3 vs
14.1 W/cm2, respectively, to map the best power density for further investigation. (B) A comparative dose-dependent relative phototoxicity of MCF-7
cells after photothermal therapy generated by free IR-820 vs IR-820 PLGA NPs having identical dye content after 808 nm laser exposure for 30 s at 14.1
W/cm2. (C) A representative scatter plot demonstrating the fraction of cells in early apoptosis (bottom right quadrant), late apoptosis (top right
quadrant), or necrosis (top left quadrant) following treatment with media only, cells + laser, IR-820-PLGA NPs only, or IR-820-PLGA NPs + laser.

Biocompatibility and Cellular Internalization Study.
The biocompatibility of free IR-820 and IR-820 PLGA NPs was
assessed in human breast cancer cell MCF-7 as presented in
Figure 5A,B for 48 h of treatment. The IR-820 dye concentration
as a handle was used to assess the biocompatibility. IR-820
PLGA NPs showed at least 80% cell viability (Figure 5A) at a
high concentration (200 μg/mL), while the viability of free IR-

presumably because the aqueous stability of IR-820 is greatly
aﬀected by the local temperature, and a high local temperature
makes free dye unstable in the suspension. In contrast to free IR820, the retention of optical density and higher order of colloidal
stability was observed in the case of IR-820 PLGA NPs. These
results demonstrate that IR-820 PLGA NPs could act as an
excellent photothermal source for therapeutic study.
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820 was found to be 42% at an equivalent concentration (65 μM
of IR-820), (Figure 5B). The dye concentration was used
according to the dye content in nanoparticles used in Figure 5A.
These data signify the biocompatibility of IR-820 PLGA NPs
even at high concentrations. We further extended our approach
to see if IR-820-loaded NPs were taken up by cells. We labeled
IR-820 PLGA NPs with Rh−B-lipid, treated with cells for 3 h,
and found that these nanoparticles were taken up by cells
(Figure 5C). To further evaluate the dose dependency and
quantitative cellular uptake of the same Rh−B-lipid-labeled
nanoparticles upon treatment and incubation for 3 h with an IR820 concentration of 20 or 60 μM, an FACS study was
performed. As shown in Figure 5D, nanoparticles were taken up
by the cells, and as expected, we observed that a signiﬁcantly
larger amount of IR-820 PLGA NPs was taken up by cells when
treated with 60 μM IR-820 content. It is worth mentioning that
this concentration of nanoparticles is well-tolerated with more
than 70% of cells being viable even at the large concentration
input of 200 μg/mL (Figure 5A). Taken together, these
observations reﬂect excellent biocompatibility and uptake of IR820 PLGA NPs signifying that it can be used as a safe
photothermal delivery agent.
NIR-Mediated Phototoxicity Study. We next investigated
the use of IR-820 PLGA NP-mediated PTT as a treatment
strategy for breast cancer and probed the mechanism of cell
death induced by this treatment modality. MCF-7 cells were
treated with 60 μM dye in IR-820 PLGA NPs, the maximum
tolerated dose determined previously (Figure 5A) for 3 h, and
then samples were irradiated with an 808 nm laser and
compared with free IR-820 having the identical dye concentration. Cells without any treatment were used as a control
throughout the treatment experiments (Figure 6A). The
combination of IR-820 PLGA NPs and laser exposure for 30 s
resulted in signiﬁcant phototoxicity having 70% and 42% cell
viability after 24 h post-treatment as measured by an MTT assay
for 5.3 and 14.1 W/cm2 laser power density, respectively, while
77% and 56% cell viability were observed for free IR-820 under
similar conditions before and after laser illumination. We note
that the laser alone or laser + PLGA NPs (without dye) has no
noticeable eﬀect on the viability of cells. These data when taken
together with aqueous photothermal eﬃciency data from Figure
6 showed that 14.1 W/cm2 is optimal for the IR-820-assisted
photothermal therapy of cancer in vitro. Additionally, we
evaluated the concentration-dependent phototoxicity at 14.1
W/cm2 while varying the IR-820 concentration in samples, both
free IR-820 and IR-820 PLGA NPs, from 1.5 to 65 μM as shown
in Figure 6B. With the increase in IR-820 content, the increase in
IR-820-assisted phototoxicity was observed after laser exposure
as measured by MTT. At lower concentrations of dye, we do not
see much diﬀerence in the phototoxicity pattern. However, the
IR-820 PLGA NPs produced signiﬁcant phototoxicity at the
concentrations of 16−65 μM when compared with its free dye
counterpart (Figure 6B).
Evaluation of the Mechanism for IR-820 PLGA NPs
Induced Phototoxicity. After the successful PTT in vitro
using IR-820 PLGA NPs, we next evaluated the mechanism of
cell death by identifying the percentage of cells undergoing
apoptosis versus necrosis using FACS study. Apoptosis is a
preferred programmed cell death pathway in a normal
physiologic process characterized by certain morphological
features, including loss of plasma membrane asymmetry and
attachment, condensation of cytoplasm and nucleus, and
internucleosomal cleavage of DNA.30 In apoptotic cells, the
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membrane phospholipid phosphatidylserine (PS) is translocated from the inner to the outer leaﬂet of the plasma
membrane, thereby exposing PS to the external cellular
environment, which upon treatment with Annexin V conjugated
to ﬂuorochromes including FIT-C, 35−36 kDa Ca2+-dependent
phospholipid-binding protein that has a high aﬃnity for PS,
binds to cells with exposed PS.49 This format retains its high
aﬃnity for PS and thus serves as a sensitive probe for a ﬂow
cytometric analysis of cells that are undergoing apoptosis. FIT-C
Annexin V staining leads to the loss of membrane integrity,
which accompanies the latest stages of cell death resulting from
either apoptotic or necrotic processes. Therefore, we stained
with FIT-C Annexin V in conjunction with PI to identify early
apoptotic cells (PI negative, FIT-C Annexin V positive). Thus,
we assessed the mechanism of cell death by ﬁrst treating cells
with no treatment versus 20 μM of IR-820 in IR-820 PLGA NPs
for 3 h and then irradiating the samples with 808 nm light for 30
s at 14.1 W/cm2. After 24 h of incubation, cells were stained with
Annexin V (FIT-C channel) and PI (PE channel) for analysis by
ﬂow cytometry. Viable cells with intact membranes exclude PI,
whereas the membranes of dead and damaged cells are
permeable to PI. As shown in representative scatter plots in
Figure 6C, cells that stain positive for Annexin V only (bottom
right quadrant Q4) are undergoing early apoptosis, while cells
that stain positive for Annexin V and PI (top right quadrant Q2)
are undergoing late apoptosis and cells that stain positive for PI
only (top left quadrant Q1) are undergoing necrosis. The ﬂow
cytometric analysis showed that IR-820 PLGA NPs induced cell
death via PTT primarily through apoptosis (52%) with no
notable increase in necrotic cell percentage (0.2%) (Figure 6C).
In contrast to the PTT using gold nanoparticles as seen in our
previous study, the rapid and high rise in the temperature in cell
suspension results in cellular necrosis where there is a reported
pro-inﬂammatory response that can elicit a negative immune
reaction that may actually promote tumor recurrence.30,50−52
Therefore, it is essential to produce normal physiological cell
death to achieve long-term survival beneﬁts. These data when
taken together with the MTT data indicate that IR-820 PLGA
NPs can successfully mediate the proapoptotic PTT of breast
cancer cells in vitro, warranting further investigation of its use in
vivo. Furthermore, because of the limitation of the Annexin V
and PI assay, which does not distinguish between cells that have
undergone apoptotic death versus those that have died as a result
of a necrotic pathway because, in either case, the dead cells will
be stained with both Annexin V and PI, we therefore
recommend that the apoptosis be measured over time so that
cells can be tracked from Annexin V and PI negative (viable, or
no measurable apoptosis) to Annexin V positive and PI negative
(early apoptosis, membrane integrity is present) and, ﬁnally, to
Annexin V and PI positive (late apoptosis and death).

■

CONCLUSION
In summary, we showed that IR-820 dye encapsulated into lipid
polymer composite nanoparticles that are monodispersed and
highly stable has optical characteristics that are maintained. The
IR-820 PLGA NPs were taken up by cells and exhibited excellent
biocompatibility as compared to the free IR-820 dye. However,
the combination of NIR laser with IR-820 PLGA NPs has
induced signiﬁcant cell death when compared to its counterpart
free IR-820 dye at an equivalent dye concentration.
Furthermore, we conﬁrmed the mechanism of NIR-mediated
cell death is mainly via apoptosis. Considering the fact that the
polymer and lipids used herein are biodegradable and Food and
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Drug Administration (FDA)-approved biomaterials, these
nanoparticles overcome the limitations of toxicity associated
with metallic especially gold and iron nanoparticle-mediated
thermal treatments. This study warranted further validation in in
vivo PTT, and the mechanism of cell death is also essentially via
apoptosis in vivo. Additionally, one could expect to compare and
contrast the photothermal eﬃciency and mechanism of cell
death of this system with gold nanoparticles for the quantitative
analysis of each system. Overall, IR-820 PLGA NPs showed
promise in the PTT, and these results lay the foundation for
further investigation.
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